+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study



A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study



American Journal of Ophthalmology 137(2): 387-8; Author Reply 388-9




(PDF emailed within 0-6 h: $19.90)

Accession: 048057915

Download citation: RISBibTeXText

PMID: 14962451

DOI: 10.1016/j.ajo.2003.10.043


Related references

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. American Journal of Ophthalmology 135(5): 688-703, 2003

Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. American Journal of Ophthalmology 137(1): 210-1; Author Reply 211-2, 2004

Latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure results of a 12 week, masked evaluator, multicenter study. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 100, 2003

A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. Clinical Therapeutics 29(9): 1915-1923, 2007

Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study. British Journal of Ophthalmology 94(1): 74-79, 2010

A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial. Journal of Ocular Pharmacology and Therapeutics 25(5): 447-451, 2010

A Comparison of Fixed Combination of Latanoprost and Timolol with Fixed Combination of Dorzolamide and Timolol in Patients With Elevated Intraocular Pressure A Three-month Masked Evaluator, Phase IIIb, Multicenter Study in the United States. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 295, 2002

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America. Clinical Therapeutics 26(5): 755-768, 2004

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: A 6-month, masked, multicenter trial. Ophthalmology 109(5): 998-1008, 2002

A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure. Journal of Ocular Pharmacology and Therapeutics 29(10): 876-881, 2014

Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group. Journal of Glaucoma 8(1): 24-30, 1999

A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe. British Journal of Ophthalmology 88(7): 877-883, 2004

Comparison of the effect of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 4362, 2003

Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 113(2): 239-246, 2006

A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure. Survey of Ophthalmology 49 Suppl 1: S19-S25, 2004